Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

PURPOSE OF REVIEW: This review describes recent advances in our understanding of a major Ca-entry pathway, the Ca release-activated Ca (CRAC) channel, that is central to mast cell activation. RECENT FINDINGS: Animals in which the genes encoding the CRAC channel have been deleted have severely compromised mast cell function and reduced allergic responses. These functional consequences reflect the ability of CRAC channels to activate a range of spatially and temporally distinct responses in mast cells, which contribute to both rapid and slow phases of an allergic response. In addition, the cells can sustain their own activation through positive feedback cycles that involve CRAC channels. Drugs that inhibit CRAC channels are proving effective in treatment of allergic responses both in vitro and in animal models of asthma. SUMMARY: CRAC channels comprise a new therapeutic target for combating allergies including asthma.

Original publication




Journal article


Curr Opin Allergy Clin Immunol

Publication Date





33 - 38


Animals, Asthma, Biophysical Phenomena, Calcium Channel Blockers, Calcium Channels, Calcium Signaling, Feedback, Physiological, Humans, Hypersensitivity, In Vitro Techniques, Mast Cells, Mice, Mice, Knockout, Nasal Polyps